Teva Pharmaceutical Industries Limited (TEV) — Capital Reinvestment Ratio
Teva Pharmaceutical Industries Limited (TEV) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow (€1.16 Billion) in capital expenditures (€142.00 Million). See TEV equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Teva Pharmaceutical Industries Limited Capital Reinvestment Ratio (2015–2025)
This chart tracks Teva Pharmaceutical Industries Limited's Capital Reinvestment Ratio across 11 annual periods. Check Teva Pharmaceutical Industries Limited cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Teva Pharmaceutical Industries Limited (2015–2025)
Year-by-year Capital Reinvestment Ratio for Teva Pharmaceutical Industries Limited from 2015 to 2025. For live market cap and broader valuation context, see Teva Pharmaceutical Industries Limited stock valuation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | €1.65 Billion | €501.00 Million | ▼ -23.9% |
| 2024 | 0.40x | €1.25 Billion | €498.00 Million | ▼ -15.8% |
| 2023 | 0.47x | €1.16 Billion | €549.00 Million | ▲ +37.7% |
| 2022 | 0.34x | €1.59 Billion | €548.00 Million | ▼ -51.1% |
| 2021 | 0.70x | €798.00 Million | €562.00 Million | ▲ +48.2% |
| 2020 | 0.48x | €1.22 Billion | €578.00 Million | ▼ -32.3% |
| 2019 | 0.70x | €748.00 Million | €525.00 Million | ▲ +163.7% |
| 2018 | 0.27x | €2.45 Billion | €651.00 Million | ▼ -32.2% |
| 2017 | 0.39x | €2.23 Billion | €874.00 Million | ▲ +69.6% |
| 2016 | 0.23x | €3.89 Billion | €901.00 Million | ▲ +66.3% |
| 2015 | 0.14x | €5.54 Billion | €772.00 Million | — |